N
Google TrendMATTHEW STONE SR (200+) — Adult victims, suspected shooter ID'd in Erie mass shooting
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:matthew stone sr200+selma blair2000+al-nassr vs neftchi fergana5000+samantha busch500+crimson rescued mountain lion cub500+peggy flanagan200+sean combs10000+boeing 747500+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Early Combination Therapy" (30 stories)

Top Headline Story

Early Initiation of Sodium–Glucose Cotransporter-2 Inhibitor-Based Fixed-Dose Combinations in Type 2 Diabetes — an Indian Expert Consensus | Gupta | Clinical Diabetology
Lead StoryVia Medica Journalsgeneral
6d ago

Early Initiation of Sodium–Glucose Cotransporter-2 Inhibitor-Based Fixed-Dose Combinations in Type 2 Diabetes — an Indian Expert Consensus | Gupta | Clinical Diabetology

<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE9KQlNRWWE3Q1h5Tm9WSWl6eEJDTkdVckoyenpfa0NfZVg5anY1MUVhZE5mcWtZSWZINTdVdmpUWnZsVE1qY29uQkYyWTVrdkJ2U3pBcFB5UTk0MDVNZUtoSnVrTk9FdktOdVhnTlJNQTZYRlUwMUdnal9R?oc=5" target="_blank">Early Initiation of Sodium–Glucose Cotransporter-2 Inhibitor-Based Fixed-Dose Combinations in Type 2 Diabetes — an Indian Expert Consensus | Gupta | Clinical Diabetology</a>  <font color="#6f6f6f">Via Medica Journals</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
200+16m ago

matthew stone sr

Adult victims, suspected shooter ID'd in Erie mass shooting

Filter stories
2000+36m ago

selma blair

Selma Blair Arrested, Attacks Flight Crew After Trying to Open Plane Door Mid-Air

Filter stories
5000+46m ago

al-nassr vs neftchi fergana

Al Nassr Asian Champions League clash in doubt over Riyadh security situation

Filter stories
500+46m ago

samantha busch

Brexton Busch honors dad Kyle with burnout, signature bow

Filter stories

Search Results for "Early Combination Therapy"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Triple combination therapy trial for HR+/HER2− breast cancer halts early due to toxicity concerns
News-Medicalgeneral

Triple combination therapy trial for HR+/HER2− breast cancer halts early due to toxicity concerns

<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxOR0NMMWtsaWtkam9EUC1oZm9rSWVndEgwaGE2cUJ6aWszeXEwaHBTcU1MZF81ckQwZ1dkR3pkUm1DNFc4bmdnYktRU05ZOUZ6RVF5dldNVzNhSEtRT2s4Nl9mOFlYYkwtVWNXNlpTOENQOGwzTVFBOXQ4RDNOakZVNEVUUUlQRjh4UVRjWjE3bmN0OTkwaDdlYWxvei1nbTZ0QVZ1eFpQV0o2SjVOYXBuZVBVWlFRWmpjcm1iRDZNREhTSEdISnQtZ3htS1pOakN1WHN2U0NWODRrZV8zX3kxTk5BY0M?oc=5" target="_blank">Triple combination therapy trial for HR+/HER2− breast cancer halts early due to toxicity concerns</a>  <font color="#6f6f6f">News-Medical</font>

Read Full StoryMore like this
ONCY Stock Heads For Sixth Straight Session Of Gains – Lead Therapy Shines in Early Combination Treatment Study
Stocktwitstech

ONCY Stock Heads For Sixth Straight Session Of Gains – Lead Therapy Shines in Early Combination Treatment Study

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxQbUY5WC11UVZJNzNHblJsamk0S1RXb1JubXFiRXFkOHhtaTlHZ1ZKSVFrQXg0Q3FWYTN3YTY5ZkM1SjR4V21aQ0w1UGNJTlJ5Q094aHJKd2Q5cFZVcEJJcUF6Q2pJTHlfTzNrT2xHU0lrdW9HUWRRcnBEa19kNVNEQWhQb05VSVZKVUd5dmlyUWRCamhkWnlrRGl1Z000N0dzbWFiSkVxRQ?oc=5" target="_blank">ONCY Stock Heads For Sixth Straight Session Of Gains – Lead Therapy Shines in Early Combination Treatment Study</a>  <font color="#6f6f6f">Stocktwits</font>

Read Full StoryMore like this
Why Early Combination Therapy Is Gaining Momentum in Young-Onset Type 2 Diabetes
Diabetes In Controltech

Why Early Combination Therapy Is Gaining Momentum in Young-Onset Type 2 Diabetes

<a href="https://news.google.com/rss/articles/CBMickFVX3lxTE5POVJ1NzBGd3RYNlpLUHl3ZGd6ZnhUZGtacTRUaG9FYTVRUF9TNkZKVXVPS2ZlX3VXSnR6dlBmWks2RG9VeTZqRkt6QUxpNURuVXV6Z1d5ZklIQ05aQzhGelZST29zQkp6MnZWVE52eWVFZw?oc=5" target="_blank">Why Early Combination Therapy Is Gaining Momentum in Young-Onset Type 2 Diabetes</a>  <font color="#6f6f6f">Diabetes In Control</font>

Read Full StoryMore like this
Exploring Treatment Paradigms in Type 2 Diabetes: A Comparison of Independent and Combined Therapeutic Approaches
Cureusgeneral

Exploring Treatment Paradigms in Type 2 Diabetes: A Comparison of Independent and Combined Therapeutic Approaches

<a href="https://news.google.com/rss/articles/CBMi5gFBVV95cUxQWENZZ0lFQmU1OC1tVVBCXy13d01SZDRLYzQ5VjNaRDNOM01OOHAtbGVxRGoxQ196cF9CS3Zqd1hqNWl0b0k0QkVNY28wbm1MYlIzaVRwZWtCTnZTN24zNm1odjdVOXcyLXd1YWQ1VTdLR1hjYlFqSmc0aExNN2g5c1g4Ujg5VlZsUjg0QkdSNW1xVE9ka0JHT0hJSThoXzFUdWFwd09sVTU2dWdmM1hKNEpzVXVJNFBVTXh1QU9JSDJob0MxYTlrd0d5OXZZWnZrem5rY3RGdEpENE5YZ1JZZmdnc1pRdw?oc=5" target="_blank">Exploring Treatment Paradigms in Type 2 Diabetes: A Comparison of Independent and Combined Therapeutic Approaches</a>  <font color="#6f6f6f">Cureus</font>

Read Full StoryMore like this
Using Dapagliflozin & Sitagliptin FDC Early in Uncontrolled T2D: A Beta Cell Preservation Approach in...
Medical Dialoguesworld

Using Dapagliflozin & Sitagliptin FDC Early in Uncontrolled T2D: A Beta Cell Preservation Approach in...

<a href="https://news.google.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?oc=5" target="_blank">Using Dapagliflozin & Sitagliptin FDC Early in Uncontrolled T2D: A Beta Cell Preservation Approach in...</a>  <font color="#6f6f6f">Medical Dialogues</font>

Read Full StoryMore like this
U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse
Bristol Myers Squibbgeneral

U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse

<a href="https://news.google.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?oc=5" target="_blank">U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse</a>  <font color="#6f6f6f">Bristol Myers Squibb</font>

Read Full StoryMore like this
Novel combination therapy yields high response rates in early-stage classical Hodgkin lymphoma
UT MD Andersongeneral

Novel combination therapy yields high response rates in early-stage classical Hodgkin lymphoma

<a href="https://news.google.com/rss/articles/CBMi-wFBVV95cUxOb1NwcXRYY002MURxbHFBSUxJcGRYLUFCa1pXTHA1b0NxSzlyeU9CTVNnOHBqWVVpVDM5bWNkZXY0aVEtSU84MGRjMjdXZFlkbEdIZ3VmNmlPT2h4RGFnN2g0TmwwTUo4WXRoUkhNbzNsVS01TFpPOXJLX3BrRGlYNlExOThvSlFZQUU4THZQdmJlTUQtcGhkX2xkUmZuXzBsSVZhRGZmTzVOd2R2eEN3YnJJX25XeV9BLVV1RThnZ3BsaFlXQ3o0UUt1YkZKaDEtZk5aejVHdDNmbTBOZUFSazJwT3g1bUt2b1ZYS09Ibk9RNnc4aElQR3pDdw?oc=5" target="_blank">Novel combination therapy yields high response rates in early-stage classical Hodgkin lymphoma</a>  <font color="#6f6f6f">UT MD Anderson</font>

Read Full StoryMore like this
Experimental drug combination shows early effectiveness in advanced kidney cancer
Mayo Clinic News Networkgeneral

Experimental drug combination shows early effectiveness in advanced kidney cancer

<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxNMzB2NEk1UUFHRDRQZU5sY3JsdEs5VlU3elpVQ0RpQXFEeFhuSVBmbE1aWFFURnJTX05FOHl2cEc1dklDdUNwcGJnNlExYmppRklDODl1cF8weHkzYUstaFc3M3k0d0tpVnRjNnRmRTNKSFRwcTdnNmxiUDVNRndJa3JVUkNHSzlMc05KeDVhdkVlN1dwX3BjdWd0eUpNYlpYb3B0VXc3Rm82VXFzM1dCbTd5VWZhUjlvTjFYd3ZtMVBzemhkZGlr?oc=5" target="_blank">Experimental drug combination shows early effectiveness in advanced kidney cancer</a>  <font color="#6f6f6f">Mayo Clinic News Network</font>

Read Full StoryMore like this
Benjamin P. Levy, MD, on Emerging Options for KRAS G12C–Mutated NSCLC: First-Line and Combination Therapies
The ASCO Postgeneral

Benjamin P. Levy, MD, on Emerging Options for KRAS G12C–Mutated NSCLC: First-Line and Combination Therapies

<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxPYUlQc3NYdVk1bWhsLWJNQ25kS1UzNUdkcS12RmxEOGpSd2VKQTdzVGlILS11TWRBSDUxaGlILU82emtRemRZTXk5SERneTR2dkRTTEt6dTRwdlk1ekd0cTRxOVJKdEtnTFZPbnZ5eUlyOUJWZDhLT0N2UDFrbzk3VHlQczNKc2UtTUU2dmt2a2NtcjlySURETGc3R3VRUHE1R182N283eFA5a1hSTVNMYmFVaEdYdkJYakVRQmZDdUhwZ2ZrQndUVQ?oc=5" target="_blank">Benjamin P. Levy, MD, on Emerging Options for KRAS G12C–Mutated NSCLC: First-Line and Combination Therapies</a>  <font color="#6f6f6f">The ASCO Post</font>

Read Full StoryMore like this
HUTCHMED Lung Cancer Combination Therapy Posts Phase III Win; Shares Surge Nearly 9% in Early Trading
BigGo Financeworld

HUTCHMED Lung Cancer Combination Therapy Posts Phase III Win; Shares Surge Nearly 9% in Early Trading

<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE55a3dIWEhxYnE5MlcwVU1iM3dIcG5DRFhiYzNoWXB1Y1ZpMXl6dzFYLXU5ZEVTTlN3WlpXRkhaNzZzbnJiZkhPNlBzZ3poWXY1dkVKQnEwRTZZMkhQbmp3VkUzSTd0UWVna19YR2hFc2t0VWJ6SVE?oc=5" target="_blank">HUTCHMED Lung Cancer Combination Therapy Posts Phase III Win; Shares Surge Nearly 9% in Early Trading</a>  <font color="#6f6f6f">BigGo Finance</font>

Read Full StoryMore like this
2025 ESC/EAS Dyslipidemia Guidelines Update: Early, Personalized, and Intensive Management for Cardiovascular Risk Reduction
Vera Healthgeneral

2025 ESC/EAS Dyslipidemia Guidelines Update: Early, Personalized, and Intensive Management for Cardiovascular Risk Reduction

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxOckZsY3gyU3JGQlJLWVVmcVoxd2w5SHhZZVRmNTVTWjJfSGRwbS1mbTRHRGFONVR4TEFvcUZxSkZLYllDZFlQV21uQmR0dko2Sy1tOGIyV0puZk9qU2FNMjFLTGJITzlSdDlPbUxRSVZjUG05dkNpbi1SUzlRN0RjTWJVR2pjcjN5TEJsS05ZdFNHOUZkWHBLYkxFeF9JODJEUGhxV0NmWVJCZkRFNHVGSjg4TVk?oc=5" target="_blank">2025 ESC/EAS Dyslipidemia Guidelines Update: Early, Personalized, and Intensive Management for Cardiovascular Risk Reduction</a>  <font color="#6f6f6f">Vera Health</font>

Read Full StoryMore like this
EHA: J&J sharpens myeloma edge as Talvey, Darzalex Faspro combo proves its worth in earlier disease stage
Fierce Pharmageneral

EHA: J&J sharpens myeloma edge as Talvey, Darzalex Faspro combo proves its worth in earlier disease stage

<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxQNmNWOEVjNTJCNHJEN1p0SzZvaDBpU3lZS3diQ3NiMzJxa19jcUJtZ1g2bzQ1dW9URHg4NmJNcnJqQ3BxQ2hBU3JSZEJpMUYzbzlvVFpXNWw0djNDTFNCd2tvUzQweFEwdVZ3bnhYZXllWUdwZEhQOElYcFk0dzhaX3lRNUdDTlVGQS1NZ0hTUHhjejJTRmc0Qm1saGNrUkxCSkVrSk93Z0pZcENERWNCcjZObVlMNk95Rnd3bWppRDZoODdt?oc=5" target="_blank">EHA: J&J sharpens myeloma edge as Talvey, Darzalex Faspro combo proves its worth in earlier disease stage</a>  <font color="#6f6f6f">Fierce Pharma</font>

Read Full StoryMore like this
The Inverted Pyramid Approach: Early Combination Therapy With Voclosporin and Obinutuzumab in Active Lupus Nephritis
Cureusgeneral

The Inverted Pyramid Approach: Early Combination Therapy With Voclosporin and Obinutuzumab in Active Lupus Nephritis

<a href="https://news.google.com/rss/articles/CBMi6gFBVV95cUxPeG43b2xRQWVMdGhkRjF2enFnVEk3ZGc3eDdmTWFFZV8tMmw4Q1BhUW5VOUZXMjB4Y01Ec1l1WHNaZi04aFBxVV8xZHVGMVdLbjNaVDNJeDNESzBFWFNvLWJJNDJsTzRRZFBld1JsdE5IYTF3Y0pxQXU4bEN3QWhYOXp5SDFRaXVBb2JfOGNyZnBudXl1NW42V09xbm13bmtfbVRFZEgzc1ItY05teEEwOUpoZzlrOWNQcmROQU95SFdqdDAwS3NLNkREekNWTzkweUd4ZzZmUzhTM0E3YldIR2tMRFd1OWVZOEE?oc=5" target="_blank">The Inverted Pyramid Approach: Early Combination Therapy With Voclosporin and Obinutuzumab in Active Lupus Nephritis</a>  <font color="#6f6f6f">Cureus</font>

Read Full StoryMore like this
Early dual-therapy could prevent thousands of heart attacks in the PHL
BusinessMirrorgeneral

Early dual-therapy could prevent thousands of heart attacks in the PHL

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxPWUlfejhyVXRsREFxSGxmUXd3WUtZX0lmVzZXZThkUE9IVWpIVGRtUXlKd2xyUmxkNFNmbGp5eDRmVk1vSEY0S3ZLR09Rc21TX2VCWEZPdDdsaU9KV0VZcDVOMkoxXzZOZG5iczM4cEctMXczb21zc2pVRWFYSWRKeVVnb2cydDFqVFFtelZCazhrZ1EtSmJYWGJvVXd2aE1PWmRvWTBMNWlzWnBwekpRYkRn?oc=5" target="_blank">Early dual-therapy could prevent thousands of heart attacks in the PHL</a>  <font color="#6f6f6f">BusinessMirror</font>

Read Full StoryMore like this
Early Combination Therapy in Type 2 Diabetes: Is Monotherapy Still Enough?
Diabetes In Controlgeneral

Early Combination Therapy in Type 2 Diabetes: Is Monotherapy Still Enough?

<a href="https://news.google.com/rss/articles/CBMiggFBVV95cUxOWU91eVhMUHprTlgyY0pLMHV0UWdDeW1xd1RoeWdRV08zandZdUMtVTJCNllhWkp4NS1ET0tjVkJmYl82WFNOVGVMWkQwUWZaT0pad1gzWlpCM2ZuRTUxd0VVVWtVU3B3UWkzM01WS29lalVuaVB4a21ORlFPd3hNRjZn?oc=5" target="_blank">Early Combination Therapy in Type 2 Diabetes: Is Monotherapy Still Enough?</a>  <font color="#6f6f6f">Diabetes In Control</font>

Read Full StoryMore like this
Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial
The Lancetgeneral

Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxObEpndHM0ZXpHMnR2SExsd2R5RnBnVWFld0pMY0FVZS1tM3lqYVBKMFZVU0F0SWEwanNOUjFpMUZsMkJxX2syaU15M05pdjBoVVNoOV9qNFQ1elZGYzhUaHRyRVRrTnE3cEI4TXpzak9oMXNrUG9QaGFuc0xHdzdqMGRBSWE5WEJUaWhr?oc=5" target="_blank">Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial</a>  <font color="#6f6f6f">The Lancet</font>

Read Full StoryMore like this
New ADA Guidelines Signal Shift in Early Combination Therapy for Type 2 Diabetes
Diabetes In Controlgeneral

New ADA Guidelines Signal Shift in Early Combination Therapy for Type 2 Diabetes

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPbDlOX3Y0M2Q4WGZNeDJSZUZoUTFzWUNtalE2MVRtWlVzV24xNHpMcHo3c04ydVpRSWdGVmZzbDJqanpvMk8xT1Y0V3BNN0xoWVRPMjZOeTZ2T1hrU0d5U3hzcDRSWEF4QWtLWFpEdXRDOHhCNHNYT0NpQlYtTWRyd2MwRXYxZzNCSGJQMU9COEhCdVdEMlBKNjdtMnNlQmtSUEIyWFY5V0tGSXFtUzUweWlhMno4dw?oc=5" target="_blank">New ADA Guidelines Signal Shift in Early Combination Therapy for Type 2 Diabetes</a>  <font color="#6f6f6f">Diabetes In Control</font>

Read Full StoryMore like this
Why SGLT2 Inhibitors and GLP-1 Combination Matters
Diabetes In Controlgeneral

Why SGLT2 Inhibitors and GLP-1 Combination Matters

<a href="https://news.google.com/rss/articles/CBMifEFVX3lxTE42cDAtV203ZXhqTG5RUDFnY0FKR1NyamN6aEJJT1pyaHBrZHpYLXZaSmFMMzdJX0VSUzRxM3k4NnR4QjNHSW5TdVRLbnF1N0dObnROaXE2TFBFR1RzTExxMUN5NTA0clhJU3Fpd1JQLUwxekFwQ1dJVHVfbTU?oc=5" target="_blank">Why SGLT2 Inhibitors and GLP-1 Combination Matters</a>  <font color="#6f6f6f">Diabetes In Control</font>

Read Full StoryMore like this
NICE Updates First-Line Type 2 Diabetes Care
Medscapegeneral

NICE Updates First-Line Type 2 Diabetes Care

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxNMU9MeVF0WWFNbWZYdkZmSG5aWUFmVVZHRlZVU1EzemowS1B4Tk1QNzdRTEZMLV9iQjRHcXd6WE4zQ2ZGR2dfNUkzekdzeTZMUm1hUzF3WE9yeURzZ21iR3FLUllOUk9TSTFPQWZmZnJ2NGpZQlF1dmR3MmN5Vm1xRVNYRFdWdkZ1SlhqZ1VBN094OE9Ja1ZZb0RR?oc=5" target="_blank">NICE Updates First-Line Type 2 Diabetes Care</a>  <font color="#6f6f6f">Medscape</font>

Read Full StoryMore like this
Early Interception: Integrating Tissue-Based Insights to Optimize ARPi+PARPi Combination Therapy in HSPC
Prostate Cancer Foundation (PCF)general

Early Interception: Integrating Tissue-Based Insights to Optimize ARPi+PARPi Combination Therapy in HSPC

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxPeVYyTDRUMDV5NlhxclozckJzSlVxLTZYUFdKaG4xZlNudDdnQUtySEZJRkRvdFZuUnhzTkhFV2xIZng2R3BxcHdfTVZ5Q09kb3Z4OXptNnlZTHhqRUYtWmRsd0k2M1Jtc2FfZTd3aVFyeHQxeVdqekZ5MWx1andvdHk1bVhPVk1kMndPc0ZFakRpRmhlVDlGdGIya0pOaDZRU3g1X3RxcHZWdmItaV8tVGpqZG5aejNibUtyS29sVk8?oc=5" target="_blank">Early Interception: Integrating Tissue-Based Insights to Optimize ARPi+PARPi Combination Therapy in HSPC</a>  <font color="#6f6f6f">Prostate Cancer Foundation (PCF)</font>

Read Full StoryMore like this
Combination therapy may help overcome barrier in early-stage prostate cancer treatment
News-Medicalgeneral

Combination therapy may help overcome barrier in early-stage prostate cancer treatment

<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxQTlgwNzVGajhES0Jsc256RzVobVJPczNwTUJoN3VBVHJMVVFBakNQTVNwMW5BamZJREdHcHZzQ0VJdWNBUUpkRGp6TGpiWWFWYWxCZGQycEdsN3VJejc2cGhWSVBOZ2hCSzE5dUdmRG15a1lkeUVsLXRHbUVEdzF0R3UyZFphZkZnejlMaW9pUXhYcFMxbkxtSmRTNmNiVTJrZkI4ZWNpM1hYZDV0SEpEdjJZQm41RU1Lb1kySkg2T0JzZ1dYaDFMQzRLaW5vZ3c?oc=5" target="_blank">Combination therapy may help overcome barrier in early-stage prostate cancer treatment</a>  <font color="#6f6f6f">News-Medical</font>

Read Full StoryMore like this
Quick Take: Glycemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY)
2 Minute Medicinegeneral

Quick Take: Glycemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY)

<a href="https://news.google.com/rss/articles/CBMiswJBVV95cUxQZGZaOUpNZ1lPbUx1VldCM0hnc25nSGdzQVg2OXVoSlNycHJnRlVuTFh1RTB4T0FzT2hydWZiR1RBbkJkaVVGUDBqODZJNmlQZTNoSTVaTFZJMlp2ZEwycDl0T3Nnd3lrTUQxMk01SGt6VTlYU1R1VnRlSjkybERuZGRlVkhHdG1nbjljc0pQaGFoSDFNYWtaZVhhSTBGRVVfcFYyVU1oQU5DWWFOdHJab3MyZHRXaDREb0FJc1JBaHhUSHhnbURIVHB6NGJqdFYwbU9hSGE2Q0ZsQWljTldXSGw4UUZObzV3M25weTNpeHZrYm81UExjMWE1eVdtX2oyX0xUVjFZSTNiaFAteWFheUdMOW9VM3dHOUpzcTVZQjhTYzhIR08yQ3poSnFvakNCdWRF?oc=5" target="_blank">Quick Take: Glycemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY)</a>  <font color="#6f6f6f">2 Minute Medicine</font>

Read Full StoryMore like this
ADA Guidelines Recommend Earlier Combination Therapy
Diabetes In Controlgeneral

ADA Guidelines Recommend Earlier Combination Therapy

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxPZFh0UUo2Z3I4WEl5cDlCX2VVdjdrR3pXUUxtV0ZFU0V6T0JTWG9HaTdaMW8zNUxoWGtkV0EtaC1KVUUyM1o3WmdybDA5VXBRdXpLSHB6SEtUOXBQUGdBdE9SemhUa1RXZmtmVlJxSm90X3JPYzNPdUYxQ1FrQnpPUVhZVHpTMmZ0VU9PQ3h0LUI?oc=5" target="_blank">ADA Guidelines Recommend Earlier Combination Therapy</a>  <font color="#6f6f6f">Diabetes In Control</font>

Read Full StoryMore like this
Fixed-Dose Combination Lowers Rates of Heart Failure for Patients With Type 2 Diabetes
Drug Topicstech

Fixed-Dose Combination Lowers Rates of Heart Failure for Patients With Type 2 Diabetes

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxNM1FhSERvV21lZE9TazNzMTFCQW9ZVTh6U21pVjhiS2xQc2RaZy1WVlpRMFIydmZjMk1XcjRpdkFUU3hmaVhiQ050cnRneF9zS3lfSUpIZ01ndjdJZHFhWTRFZGxjYnNWUTFMZF9HRmhta0cwa1N0WmFkV1FvVjFVd0Nqbm1FaEhnelBtVjhxLTlhWF9yT2NIOEFlcWNaY2dDZXd5SzY1X2ZBSFMtX3RYRHdieWpONTgtMVE?oc=5" target="_blank">Fixed-Dose Combination Lowers Rates of Heart Failure for Patients With Type 2 Diabetes</a>  <font color="#6f6f6f">Drug Topics</font>

Read Full StoryMore like this
Double Down on Single-Tablet Combination Therapy in Pulmonary Arterial Hypertension:
JACC Journalsgeneral

Double Down on Single-Tablet Combination Therapy in Pulmonary Arterial Hypertension:

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE9rOEZYTXQ1ZGV6cTlGVHpFVWhvRk1zWEkwaEx0Nm4tUXpTZnlGTmRmX0Y3Ums5SzZQdUxhc0ZFZHlMa2MxaVQ5Z2V2cl84Mms0ZWFRc196V1o2VUdVU295ZQ?oc=5" target="_blank">Double Down on Single-Tablet Combination Therapy in Pulmonary Arterial Hypertension:</a>  <font color="#6f6f6f">JACC Journals</font>

Read Full StoryMore like this
Complications of Type 2 Diabetes: Why Early Intervention Is More Critical Than Ever
Diabetes In Controlgeneral

Complications of Type 2 Diabetes: Why Early Intervention Is More Critical Than Ever

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxNNEctTjJiUDdrWmM5NzRuZGxFcHhCSmZ0Nzg4M295VFROMjNYcHRZVWwtbEY1elRvR0NnNmtZa2h4NjdwbzlVNWRaUE5FdGlUNll6WXFBOEkwSEJRTzVpVUp6UmtmT2xvU3RPVDY0VUI5SFZ1QlhwYVpIeHhtaGNkUnZOODVQT2xyTmFGS1MtMmlJRk54VnE1eXpTdUYtdlZtWjRWQ2tPSkphNUVvZ0JpUUNyR3JLY0hN?oc=5" target="_blank">Complications of Type 2 Diabetes: Why Early Intervention Is More Critical Than Ever</a>  <font color="#6f6f6f">Diabetes In Control</font>

Read Full StoryMore like this
Early Combination of Lipid-Lowering Therapy Beneficial After Myocardial Infarction
Diabetes In Controlgeneral

Early Combination of Lipid-Lowering Therapy Beneficial After Myocardial Infarction

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxNYXU2dUJ3VmcyR0tGNW9lQXBQMktsQ2c2YjJVVXUzNjhUS1ctc3RqSGVNb0JzN21JeEQwWG96cGk0bDVOZTd0NWh6d2k1cHRjNVVjUWRsM1RfeHIyeUZmY0swWHNScHktN3puSEpRQV9vQ2RNZTJKUzBhdlU3dll2cG4tT29xS3FGekxnNWVZbWhBaklXU0I1S1k2d2otRjg1ZzRGMTBjdzhDcHpaVURPRmZmR3NxUlR6?oc=5" target="_blank">Early Combination of Lipid-Lowering Therapy Beneficial After Myocardial Infarction</a>  <font color="#6f6f6f">Diabetes In Control</font>

Read Full StoryMore like this
Optimizing Cardiovascular Outcomes in Type 2 Diabetes: Early Initiation of Dapagliflozin and Sitagliptin From a Cardiologist's Perspective
Cureusgeneral

Optimizing Cardiovascular Outcomes in Type 2 Diabetes: Early Initiation of Dapagliflozin and Sitagliptin From a Cardiologist's Perspective

<a href="https://news.google.com/rss/articles/CBMihgJBVV95cUxPSDZxcnZRUzVUcFcwc3doWWN4SVFySGQzSkNwYmZFT2V1aDFjX3BMX0h5OVJVSEthMVU4Z2xXVjVMQjBTVTJKUWtYWlF3WkU4TS1QQlJISXd5SFBhX1JuZmVDQXlNYURfeS16Vi0tZVVsLS1kNHVBajZGUWlReEtQOWt0QzNXWF9hSUlsLUViTWN2Y1FTZ3E0VHpfVUFrNllPZGl3NlBpQkZ5V1FmWmRIVU9vU19fSWJsdWsyZllGRk9DRFkzRkVzVlNOVjF4UVNfLXBnR1ozQVkxZEZZNXc4YUFFaFc2OVJOME5oVTNheHRQcW9UcmdOS1RzZ19fTmx6SEEzNHVR?oc=5" target="_blank">Optimizing Cardiovascular Outcomes in Type 2 Diabetes: Early Initiation of Dapagliflozin and Sitagliptin From a Cardiologist's Perspective</a>  <font color="#6f6f6f">Cureus</font>

Read Full StoryMore like this
New Hypoglycemic Drugs: Combination Drugs and Targets Discovery
Frontiersgeneral

New Hypoglycemic Drugs: Combination Drugs and Targets Discovery

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxQc2VUUVhRMU1VMndremdOdzJUclVtYVI0NnVla3dIQXJoWjY4OUlJQlJ4ZjZudzhRV3BReG84Wnl1X2xfMWtTMFp1MHhna3FXNm9QRW0zNTk5Z25fQ0ctN01rNlFUS3ZWcHgtWTJWUHo0dWg2cFYtSEIyYUFPRUVXLXJ0YnpwdjRuZXRzTGtLZXZGQTA?oc=5" target="_blank">New Hypoglycemic Drugs: Combination Drugs and Targets Discovery</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
"Early Combination Therapy" — Live Google News Trends & Headlines